Psychosine Alleviates Colitis via Inhibiting Th1 and Th17 Cell Immune Responses in Inflammatory Bowel Diseases

Documenti analoghi

• The Emerging Role of CCL17 in the Immunologic Regulation of Inflammatory Bowel Disease
  di: Cong Zhang, et al.
  Pubblicazione: (2025)
• Multiple Roles and Therapeutic Targets of Tuft Cells in Inflammatory Bowel Disease
  di: Mohamad Norouzi Masir
  Pubblicazione: (2026)
• Role of the Dietitian in the Inflammatory Bowel Disease Multidisciplinary Team
  di: Nicky E. McCarthy, et al.
  Pubblicazione: (2025)
• Bile Acid Metabolites Control Th17/Treg Balance in Primary Biliary Cholangitis: Mechanisms of Disease Progression and Therapeutic Targets
  di: Zhiqian Liu, et al.
  Pubblicazione: (2025)
• Hederagenin Alleviates Ulcerative Colitis via Suppressing the Activation of EGFR/p38 MAPK Signaling
  di: Lu Jiang, et al.
  Pubblicazione: (2026)